Asia Pacific countries have written the plans to tackle antimicrobial resistance, but a new report shows many still struggle to fund them from their own budgets.
WHO estimates 5.2 million casualties by 2030, costing $148b. Fewer than half of Asia-Pacific countries fund their antimicrobial resistance (AMR) response mainly from domestic sources, according to a BMJ Journals report. The report noted that domestic funding was below 30% in 15 of 27 countries (56%).
All four high-income countries and two Pacific Island countries reported 100% domestic funding, whilst lower-middle-income countries ranged from 5% to 60%. Of the 38 Asia Pacific countries, 89% had endorsed at least one multisectoral national action plan (NAP), and four had none. Amongst the 27…
Read the full report on Healthcare Asia Magazine
Story file
- Section
- Health
- First reported by
- Healthcare Asia Magazine
- Reporter
- staff reporter
- Published
- Friday, 9 October 2026, 2:30 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Healthcare Asia Magazine with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.
